Final Programme - iuphar

FC13 Maximising benefits and minimising harms from
drugs
Organized by the British Pharmacological Society
Leaders: Munir Pirmohamed, (UK) & Brian Kevin Park, (UK)
FC13.1 Drug safety: The epidemiology
Chairs: Kees van Grootheest, (The Netherlands) & Alasdair Breckenridge, (UK)
09:30 - 09:55 FC13.1.1 Adverse drug reactions in hospitals
Kees van Grootheest, (The Netherlands)
09:55 - 10:20 FC13.1.2 An industry perspective of drug safety
Michael A Ibara, (USA)
10:20 - 10:45 FC13.1.3 Drug regulation and drug safety
Alasdair Breckenridge, (UK)
10:45 - 11:15 COFFEE BREAK
11:15 - 11:40 FC13.1.4 Clinical toxicology perspective of drug safety
Simon Thomas, (UK)
11:40 - 11:55 FC13.1.5 Free Communication Presentation:
Health alliance for prudent prescribing, yield and use of antimicrobial drugs in the
treatment of respiratory tract infection (HAPPY AUDIT)
Lars Bjerrum, (Denmark), MP Hansen, JM Cots, C Llor, A Munck, B Gahrn-Hansen
11:55 - 12:10 FC13.1.6 Free Communication Presentation:
A drug burden index (DBI) to improve quality use of medicines in Australian war veterans
and widows
Danijela Gnjidic, (Australia), S Hilmer, E Roughead, A Gilbert, D Le Couteur, D Abernethy
Wednesday 21 July ■ 09:30 - 12:15 ■ Hall A2 95